Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Yale School of Medicine
Headquarters: New Haven, CT, United States of America
Website: http://medicine.yale.edu
Year Founded: 1810
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Jul 30, 2024
Product Development
Eisai’s new data provide insight into how to get the most out of anti-amyloid mAbs
Three-year Leqembi readout in tau subgroup may be most impressive amyloid mAb data to date
BioCentury | Jun 29, 2024
Regulation
Cardiologists voice safety concerns about Sarepta’s Elevidys
Safety data are missing from the older and non-ambulatory DMD populations FDA recently added to the gene therapy’s label
BioCentury | May 31, 2024
Distillery Therapeutics
Inhibiting GLIS2 for autosomal dominant polycystic kidney disease
BioCentury | Apr 18, 2024
Management Tracks
Protego names Warner CEO
Plus: Foghorn hires Humer and updates from Javelin, Stoke, Sensorium, Theradaptive and more
BioCentury | Jan 12, 2024
Discovery & Translation
Voltage-gated sodium channel insights outside of pain
Researchers link Nav1.7 to osteoarthritis progression and identify a modulator of Nav1.6 for epilepsy
BioCentury | Dec 4, 2023
Distillery Therapeutics
A trivalent nanoparticle vaccine for Merbecoviruses and Sarbecoviruses
BioCentury | Sep 7, 2023
Product Development
ARPA-H supports a new side of mRNA research
Emory-led project gains ARPA-H backing to control immune cell function
BioCentury | Dec 7, 2022
Product Development
ASH22 could be IL-18’s watershed moment
CAR T data at ASH could trigger more development in one of oncology’s less crowded cytokine spaces
BioCentury | Nov 23, 2022
Data Byte
Translational spotlight on East-West innovation
Collaborations between investigators at Asian and Western universities in BioCentury’s Distillery present licensing and partnering opportunities
Items per page:
1 - 10 of 170